Cost‐Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension

Primary aldosteronism (PA) is present in up to 20% of patients with treatment‐resistant hypertension (TRH). Investigation for PA in patients with TRH is recommended by current guidelines after medication nonadherence is excluded. Studies using therapeutic drug monitoring (TDM) have shown that >50...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Hypertens (Greenwich)
Main Authors: Velasco, Alejandro, Chung, Oliver, Raza, Fayez, Pandey, Ambarish, Brinker, Stephanie, Arbique, Debbie, Price, Angela, Lotan, Yair, Das, Sandeep R., Vongpatanasin, Wanpen
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2015
Teme:
Original Papers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4562815/
https://ncbi.nlm.nih.gov/pubmed/25917401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12570
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki